Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

EVMN FY 2023 Earnings — Evommune, Inc. Revenue & Financial Results | Market Cap Arena

EVMNEvommune, Inc.

$319M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$4M80.0% margin

Operating Income

-$38M-757.0% margin

Net Income

-$34M-681.1% margin

EPS (Diluted)

$-1.13

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$82M

Total Liabilities

$160M

Stockholders' Equity

-$78M

Cash & Equivalents

$29M

← Q1 2024 All Quarters